Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US FDA has granted approval to Onco Therapies, a subsidiary of Strides Arcolab, an Indian pharmaceutical company, to market its Doxorubicin Hydrochloride injection in the US market.
Subscribe to our email newsletter
The injection is indicated to treat cancer and is administered intravenously, hindubusinessline.com reported.
The drug in the strengths of 10 mg/ vial and 50 mg/ vial, received approval
The Hindu Business Line quoted Strides Arcolab as saying that the drug belongs to the oncology portfolio licensed to Pfizer in January 2010 for the US market.